HealthCor Management praised Magellan's growth, but called the company's plan to use its high cash balances to make acquisitions "problematic." HealthCor says that returning cash to shareholders would be the best means of maximizing value. It called for Magellan to use $300 million of its excess cash for this purpose. HealthCor reported holding 2.75 million shares (6.83% of the total outstanding).

Carlson Capital said it has had discussions with Energy Partners about possible changes to the company's board. The investor reiterated that it may seek board representation or work with Energy Partners on strategies to increase shareholder value. Carlson may communicate with one or more shareholders, officers or board members for this purpose. Carlson owns 2,994,968 shares (9.4%).

Activist investor Carl Icahn has suggested that the biopharmaceutical company consider spinning off certain assets or selling itself. Icahn would like management to review strategic transactions that could enhance shareholder value. His affiliates reported holding about 3.07 million shares (6.93%). Icahn has long exposure to an additional 3.55 million Enzon shares through swap agreements.

Barrow Hanley stated that it is considering withholding its support for re-election of the company's slate of directors at the 2008 annual meeting.

Ramius LLC said that it's "supportive" of Datascope's intention to return the proceeds from the $202 million sale of its Patient Monitoring business to shareholders through a stock buyback or special dividend. Ramius said that the proposed transaction is "in the best interest of all shareholders." Ramius may communicate with management and the board regarding the most beneficial way to return the proceeds to shareholders. Ramius holds 1,041,676 shares (6.7%).

Advisory Research raised its stake to about 2.78 million shares (11.9%) from the 2.53 million (10.8%) reported on March 18.

David Nierenberg's D3 Family Funds raised their stake to 11.77 million shares (7.8%) from the 9.93 million (6.6%) reported on March 7. Nierenberg has recently called for Move's board to dismiss CEO Mike Long and CFO Lew Belote. He also called for the company to sell its money-losing businesses.

ValueAct Capital Management cut its holdings to 58.6 million shares (4.7%) from the 78.9 million (6.2%) it reported owning on Nov. 7.